Further, Zhang and Kschischo [103] showed that cells with W-CIN are susceptible to treatment with a BRAF inhibitor (PLX-4032), and those with S-CIN respond to Afatinib, Lapatinib and Austocystin. The gene discussed is BRAF; the disease is cervical squamous intraepithelial neoplasia.